Among them, phenotype group 3, prevalent in patients with obesity and diabetes mellitus, was characterized by systemic inflammation with elevated levels of inflammatory factors, especially TNF-α and renin, and a preferential response to spironolactone (55, 56). Here, TNF is linked to obesity disorder.